The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.20
Bid: 17.80
Ask: 18.60
Change: 0.15 (0.83%)
Spread: 0.80 (4.494%)
Open: 18.05
High: 0.00
Low: 0.00
Prev. Close: 18.05
LMS Live PriceLast checked at -
LMS Capital is an Investment Trust

To achieve absolute total returns over the medium to longer term, principally through capital gains and supplemented with the generation of a longer term income yield, by investing primarily in private equity.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter 2018 update

27 Apr 2018 07:00

RNS Number : 3135M
LMS Capital PLC
27 April 2018
 

27 April 2018

 

 

LMS Capital plc

1st Quarter 2018 update

 

 

LMS Capital plc ("LMS" or "the Company") is issuing the following update covering the period from 1 January 2018 to date.

 

31 March 2018 Net Asset Value

 

The Company's unaudited net asset value ("NAV") at 31 March 2018 was £60.2 million (31 December 2017 £64.5 million), equivalent to 75p per share (31 December 2017: 80p per share). The most significant movements in the quarter were:

 

· A strengthening of sterling against the US Dollar and decreases in prices of quoted securities in the period from I January 2018 to 31 March 2018 account for £3.8 million of the reduction in NAV. The principal items within this are:

o IDE Group plc share price reduction £1.4 million;

o Weatherford share price reduction £0.7 million

o An adverse change of approximately 3.7% in the sterling/US Dollar exchange rate over the period has resulted in a reduction in NAV of £1.5 million

· Other net changes amount to a £0.5 million reduction. In addition to operating costs, the main items are:

o Gain on sale of Brockton Capital LLP of £0.6 million. As announced by the Company on 26th March, actual proceeds were £3.1m. This amount, which included a distribution of surplus cash in the vehicle sold, exceeded by £0.6 million, the estimate used in the 31 December 2017 NAV;

o Reduction of £0.7 million in the carrying value of Medhost, a co investment with Primus Capital which is the lead manager. The reduction is based on Primus Capital's most recent reported carrying value published late March.

 

The reduction in share price of IDE Group between the end of December 2017 and end of March 2018 followed a number of announcements in the first quarter. However, the company has confirmed that trading for the year to 31 December 2017 was broadly in line with expectations, although cash generation was weaker than expected. Full year results are due for release in early May.

 

The NAV at the end of March is based on the valuation of the Company's investments as at 31 December 2017, adjusted for transactions in the three months ended 31 March 2018, price movements on quoted securities, movements in foreign currency exchange rates, cash calls and distributions from funds, latest reports from third party fund managers, purchases and sales of quoted and unquoted securities and operating expenses.

 

Since the end of March, further movements in the prices of the Company's quoted investments and changes in the sterling/US Dollar exchange rate have not had a significant impact (either individually or in aggregate) on the Company's NAV as at the end of March.

 

Portfolio management

 

Gresham House Asset Management ("GHAM") continues to manage the portfolio through its board representation on those investments where LMS has board rights and through maintaining regular dialogue and meetings with third party managers and others.

 

During the period since 1 January 2018 the principal portfolio events have been the conclusion of the sale of the Company's interest in Brockton Capital LLP and an investment of £600,000 in Northbridge Industrial Services PLC ("Northbridge"), an AIM quoted company that hires and sells specialist industrial equipment to utilities, public sector and oil and gas industries. The Northbridge investment is via a participation in an 8% p.a. yielding convertible loan instrument. The investment was sourced by GHAM and is the Company's first investment, other than follow on investments in the existing portfolio, since the conclusion of its realisation strategy and adoption of its new investment policy in August 2016.

 

Strategy and outlook

 

Liquidity events on the Company's larger investments are controlled by third party managers, however, based on the information available, the Company believes there is the reasonable prospect of liquidity from the existing portfolio over the next 18 months. The proceeds from the sale of Brockton Capital LLP have provided the Company with some liquidity to commence new investment activities.

 

The Board and the manager continue to evaluate strategic options for the Company to increase scale and enhance shareholder value.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse regulations (EU) No. 596/2014. Upon publication of this announcement this inside information is now considered to be in the public domain.

 

For further information please contact

 

LMS Capital plc

Martin Knight, Chairman 0203 837 6270

 

Gresham House Asset Management Limited

Graham Bird 0203 837 6270

 

J.P. Morgan Cazenove

Michael Wentworth-Stanley 0207 742 4000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDPGURPCUPRGMQ
Date   Source Headline
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23
23rd May 20234:03 pmRNSDividend Declaration - REPLACEMENT
18th May 20234:08 pmRNSDividend Declaration
18th May 20234:03 pmRNSResult of AGM
5th May 20237:00 amRNSStatement re Notice to shareholders
28th Apr 20237:00 amRNSFirst Quarter 2023 Update
24th Apr 20232:42 pmRNSNotice of AGM
24th Apr 20232:37 pmRNSNotice of AGM
14th Apr 202310:47 amRNSHolding(s) in Company
22nd Mar 20233:04 pmRNSHolding(s) in Company
20th Mar 20237:00 amRNSFinal Results fo rthe Year Ended 31 December 2022
7th Feb 20237:00 amRNSNet Asset Value(s)
25th Nov 20223:54 pmRNSHolding(s) in Company
28th Oct 20227:00 amRNSThird Quarter 2022 Update
2nd Aug 20227:09 amRNSHalf year Report and Dividend declaration
19th May 20223:42 pmRNSDividend Declaration
18th May 20224:27 pmRNSResult of AGM
27th Apr 20227:00 amRNSFirst Quarter 2022 Update
22nd Apr 20227:00 amRNSNotice of Annual General Meeting 2022
10th Mar 20227:00 amRNSFinal Results for the Year Ended 31 December 2021
31st Jan 20227:00 amRNSNAV Estimate as at 31 December 2021
15th Dec 20214:41 pmRNSSecond Price Monitoring Extn
15th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSPortfolio Update
12th Nov 202112:34 pmRNSPortfolio Update
22nd Oct 20217:00 amRNSThird Quarter 2021 Update
23rd Sep 202112:16 pmRNSHolding(s) in Company
4th Aug 20217:00 amRNSDividend Declaration
3rd Aug 20217:00 amRNSHalf-year Report
8th Jul 202110:16 amRNSChange of Registered Office
18th May 20214:36 pmRNSPrice Monitoring Extension
13th May 20213:32 pmRNSFinal Dividend for the year ended 31 December 2020
12th May 20214:20 pmRNSResult of AGM
29th Apr 20217:00 amRNSFirst Quarter 2021 Update
9th Apr 20217:00 amRNSAnnual Financial Report
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:35 pmRNSPrice Monitoring Extension
12th Mar 20217:09 amRNSFinal Results for the Year Ended 31 December 2020
2nd Mar 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.